Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 June 2026

Human medicines European public assessment report (EPAR): Fingolimod Mylan, fingolimod, Date of authorisation: 18/08/2021, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Deferasirox Mylan, deferasirox, Date of authorisation: 26/09/2019, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Azacitidine Mylan, azacitidine, Date of authorisation: 27/03/2020, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Fubelv, etanercept, Date of authorisation: 23/04/2026, Revision: 1, Status: Authorised

Product Management Service (PMS) public API - Frequently asked questions (FAQs)

Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

PSUSA/00000892/202511

Human medicines European public assessment report (EPAR): Posaconazole Accord, posaconazole, Date of authorisation: 25/07/2019, Revision: 13, Status: Authorised

Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meetings